Cargando…
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review
Convalescent plasma therapy (CP) has long been used to prevent and treat various infectious diseases before COVID-19 such as SARS, MERS, and H1N1. Because the viral and clinical characteristics of COVID-19 share the similarities between SARS and MERS, CP treatment could be a promising treatment opti...
Autores principales: | Munir, M.A., Tandiabang, P.A., Setyawati, T., Basry, A., Cyio, A.D., Rahman, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028602/ https://www.ncbi.nlm.nih.gov/pubmed/33839300 http://dx.doi.org/10.1016/j.tracli.2021.03.005 |
Ejemplares similares
-
A medical ethics review of elective orthopaedic surgery management during the pandemic COVID-19 Era
por: Munir, Muhammad Ardi, et al.
Publicado: (2022) -
Current Perspectives of convalescent plasma therapy in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2020) -
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020) -
COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022) -
Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)